News

All articles

News2 min read

Minister visits Sterling’s new Ringaskiddy facility Read more

Blog2 min read

Sterling's Dudley facility achieves gold status Better Health at Work Award Read more

News2 min read

Sterling completes acquisition of API manufacturing facility in Ringaskiddy, Ireland Read more

News2 min read

Sterling recognised for exceptional performance with BVCA award Read more

Sterling donates to children's programme

Blog3 min read

Sterling and ITS donate to Children Challenging Industry Programme Read more

Blog2 min read

Biocatalysis Chemist receives Newcastle University alumni achievement award Read more

News2 min read

Sterling wins Manufacturing Award at North East Business Awards 2022 Read more

News2 min read

Sterling’s CEO nominated as top 10 leader in small molecules Read more

News2 min read

Sterling expands ADC capabilities and laboratory capacity at Deeside

Sterling Pharma Solutions today announced a £1 million expansion project at its Deeside, UK site, which is the company’s dedicated bioconjugation and antibody-drug conjugates (ADCs) facility. The project will increase the current laboratory space from 275 to 419 square meters and establish cGMP bioconjugation/ADC manufacturing capabilities.

Explore more

All ADCs API Development API Manufacturing Analytical Services Drug Discovery Facilities News PDMO People Peptides Sustainability Technologies

Sign up for updates

Be the first to see the latest articles and updates from industry leaders, delivered straight to your inbox

This field is for validation purposes and should be left unchanged.

Name(Required)

Email(Required)

Company Name(Required)

This field is hidden when viewing the form

Prospect Source

Please click here for our privacy policy